Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.

doi:10.1002/ajh.21556

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.

American journal of hematology - 1 Dec 2009

Kim Hee Nam, Kim Nan Young, Yu Li, Kim Yeo-Kyeoung, Lee Il-Kwon, Yang Deok-Hwan, Lee Je-Jung, Shin Min-Ho, Park Kyeong-Soo, Choi Jin-Su, Kim Hyeoung-Joon

Abstract excerpt

Drug metabolizing genes are involved in the detoxification of chemical carcinogens. Polymorphisms in drug-metabolizing genes affect the risk of some forms of cancer. We analyzed six polymorphisms to evaluate their association with risk for non-Hodgkin lymphoma (NHL), and to examine whether smoking modifies these associations in population-based study in Korea (713 cases and 1,700 controls). The GSTP1 rs1695 AG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP1A1

Share to Glutathione S-Transferase pi

Share to Glutathione Transferase

Share to Lymphoma, Non-Hodgkin

Share to NAD(P)H Dehydrogenase (Quinone)

Share to Republic of Korea

Share to Smoking

Source

Open in PubMed

Identifiers

PMID: 19899130
DOI: 10.1002/ajh.21556

Genes

GSTP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.PMID 19899130Read ↗

Metabolic gene variants and risk of non-Hodgkin's lymphoma.Semantic proximity Read ↗

Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma.Semantic proximity Read ↗

Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.Semantic proximity Read ↗

Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.Semantic proximity Read ↗

The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients.Semantic proximity Read ↗

Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma.Semantic proximity Read ↗

Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival.Semantic proximity Read ↗

Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk.Semantic proximity Read ↗

Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma.Semantic proximity Read ↗

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.Semantic proximity Read ↗

Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.Semantic proximity Read ↗

Role of genetic factors in development and progression of non-Hodgkin's lymphomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.